A sensitive bioanalytical method development and validation of cabozantinib in human plasma by LC-ESI-MS/MS. (2018). Brazilian Journal of Pharmaceutical Sciences, 54(2), e17163. https://doi.org/10.1590/s2175-97902018000217163